These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8744565)

  • 1. Quantitative determination of immune response against hepatitis A virus capsids after natural infection.
    Wang CH; Tschen SY; Flehmig B
    Vaccine; 1996 Mar; 14(4):355-6. PubMed ID: 8744565
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune response to hepatitis A virus capsid proteins after infection.
    Wang CH; Tschen SY; Heinricy U; Weber M; Flehmig B
    J Clin Microbiol; 1996 Mar; 34(3):707-13. PubMed ID: 8904442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological approaches to distinguish immune response to hepatitis A vaccine and natural infection.
    Robertson BH; Jia XY; Tian H; Margolis HS; Summers DF; Ehrenfeld E
    Vaccine; 1992; 10 Suppl 1():S106-9. PubMed ID: 1335637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protracted course hepatitis A].
    Garavelli PL; Orsi PG
    Minerva Dietol Gastroenterol; 1989; 35(1):65-6. PubMed ID: 2725931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient immunoglobulin M antibody response to hepatitis C virus capsid antigen in posttransfusion hepatitis C: putative serological marker for acute viral infection.
    Chen PJ; Wang JT; Hwang LH; Yang YH; Hsieh CL; Kao JH; Sheu JC; Lai MY; Wang TH; Chen DS
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5971-5. PubMed ID: 1321429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of immunoglobulin A in serum and saliva of patients with hepatitis A].
    Más Lago P; Balmaseda A; Galván E; Rodríguez L; Castillo A
    Rev Cubana Med Trop; 1994; 46(1):16-9. PubMed ID: 9768227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the prevalence of IgG antibodies to hepatitis E virus and hepatitis A virus in members of households in the Mekong delta region of Vietnam.
    Kolaitis N
    Am J Trop Med Hyg; 2000 Jan; 62(1):1. PubMed ID: 10761716
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute viral hepatitis A patient with early negative HAV-IGM antibody.
    Wilairatana P
    Southeast Asian J Trop Med Public Health; 1996 Mar; 27(1):202-3. PubMed ID: 9031430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-exposure prophylaxis for hepatitis A: immune globulin, vaccine or both?
    Allam MF
    J Prev Med Hyg; 2008 Dec; 49(4):129-30. PubMed ID: 19350959
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosis of hepatitis A, B, and C using oral samples.
    Piacentini SC; Thieme TR; Beller M; Davidson SL
    Ann N Y Acad Sci; 1993 Sep; 694():334-6. PubMed ID: 8215081
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of hepatitis A vaccination schedules on immune response.
    Tilzey AJ; Palmer SJ; Barrow S; Perry KR; Tyrell H; Safary A; Banatvala JE
    Vaccine; 1992; 10 Suppl 1():S121-3. PubMed ID: 1335640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of synthetic peptides for hepatitis A diagnosis using biosensor technology.
    Gómara MJ; Ercilla G; Alsina MA; Haro I
    J Immunol Methods; 2000 Dec; 246(1-2):13-24. PubMed ID: 11121543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indigenous anti-hepatitis A virus IgM capture ELISA for the diagnosis of hepatitis A.
    Chitambar SD; Murthy-Grewal S; Bokil M; Arankalle VA; Gore MM; Banerjee K
    Indian J Med Res; 1994 Jun; 99():243-51. PubMed ID: 8088883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development and evaluation of an ELISA for the detection of IgM antibodies against the hepatitis A virus].
    Rodríguez Lay L; Más Lago P; Balmaseda A; Comellas MM; Delgado G; Palomera R
    Rev Cubana Med Trop; 1994; 46(2):86-9. PubMed ID: 9768241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of linear and multiple antigenic peptides in the immunodiagnosis of acute hepatitis A virus infection.
    Gómara MJ; Riedemann S; Vega I; Ibarra H; Ercilla G; Haro I
    J Immunol Methods; 2000 Feb; 234(1-2):23-34. PubMed ID: 10669766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of antibodies to the nonstructural 3C proteinase of hepatitis A virus.
    Stewart DR; Morris TS; Purcell RH; Emerson SU
    J Infect Dis; 1997 Sep; 176(3):593-601. PubMed ID: 9291304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors and prevalence of antibodies against hepatitis A virus (HAV) in children from day-care centers, in Goiania, Brazil.
    Queiróz DA; Cardoso DD; Martelli CM; Martins RM; Porto SO; Borges AM; Azevedo MS; Daher RR
    Rev Inst Med Trop Sao Paulo; 1995; 37(5):427-33. PubMed ID: 8729753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of hepatitis A virus markers in Eastern Saudi Arabia.
    Fathalla SE; Al-Jama AA; Al-Sheikh IH; Islam SI
    Saudi Med J; 2000 Oct; 21(10):945-9. PubMed ID: 11369959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of antibodies against hepatitis A virus (HAV) in a population of Mexican children].
    Ramirez Mayans JA; Cervantes Bustamante R; Jiron Castro R; Oyervides Garcia CI; Mata Rivera N; Navarrete Delgadillo Natividad MA; Sosa Martinez MC
    Acta Gastroenterol Latinoam; 1997; 27(2):99-102. PubMed ID: 9412137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hepatitis A in a traveler who had received preexposure inactivated hepatitis A virus vaccine.
    Kurup A; San LM; Yew WS
    Clin Infect Dis; 1999 Jun; 28(6):1324-5. PubMed ID: 10451178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.